PURPOSE: To evaluate the relationship between (a) pathologic levels of cerebrospinal fluid (CSF) total tau as an index of the intensity of ongoing neuronal degeneration and (b) longitudinal changes in white matter (WM) integrity in patients with mild cognitive impairment (MCI). MATERIALS AND METHODS: Participants gave written informed consent, and the Norwegian committee for medical research ethics approved the study. Thirty patients with MCI and nonpathologic CSF total tau levels, nine patients with MCI and pathologic CSF total tau levels, and 16 age-matched healthy control subjects underwent diffusion-tensor imaging at baseline and after a mean follow-up of 2.6 years ± 0.54 (standard deviation), with range of 1.58-3.98 years. The effect of diagnosis (MCI vs no MCI) at baseline and CSF tau levels at fractional anisotropy (FA), mean diffusivity, radial diffusivity (D(R)), and axial diffusivity were tested with tract-based spatial statistics. Differences in WM integrity at baseline and follow-up and change over time were compared among patients with pathologic CSF total tau levels (MCI high tau), patients with normal CSF total tau levels (MCI low tau), and healthy control subjects. Linear mixed-model between-group within-subject analyses were conducted to examine differences in rate of change over time in FA and D(R). RESULTS: Longitudinal analysis of regional WM change revealed significant decrease in FA (P = .038) and increase in D(R) (P = .018) in the MCI high-tau group relative to control subjects. For D(R), the changes were regionally specific to the right cingulum and the right superior and inferior longitudinal fasciculi. CONCLUSION: Reduction in WM integrity was greater in patients with MCI who had the most intense neuronal degeneration as indexed by using CSF total tau, suggesting that these patients might represent a subgroup of MCI with more intense WM degeneration who are possibly at greater risk of developing Alzheimer disease. RSNA, 2012
PURPOSE: To evaluate the relationship between (a) pathologic levels of cerebrospinal fluid (CSF) total tau as an index of the intensity of ongoing neuronal degeneration and (b) longitudinal changes in white matter (WM) integrity in patients with mild cognitive impairment (MCI). MATERIALS AND METHODS:Participants gave written informed consent, and the Norwegian committee for medical research ethics approved the study. Thirty patients with MCI and nonpathologic CSF total tau levels, nine patients with MCI and pathologic CSF total tau levels, and 16 age-matched healthy control subjects underwent diffusion-tensor imaging at baseline and after a mean follow-up of 2.6 years ± 0.54 (standard deviation), with range of 1.58-3.98 years. The effect of diagnosis (MCI vs no MCI) at baseline and CSF tau levels at fractional anisotropy (FA), mean diffusivity, radial diffusivity (D(R)), and axial diffusivity were tested with tract-based spatial statistics. Differences in WM integrity at baseline and follow-up and change over time were compared among patients with pathologic CSF total tau levels (MCI high tau), patients with normal CSF total tau levels (MCI low tau), and healthy control subjects. Linear mixed-model between-group within-subject analyses were conducted to examine differences in rate of change over time in FA and D(R). RESULTS: Longitudinal analysis of regional WM change revealed significant decrease in FA (P = .038) and increase in D(R) (P = .018) in the MCI high-tau group relative to control subjects. For D(R), the changes were regionally specific to the right cingulum and the right superior and inferior longitudinal fasciculi. CONCLUSION: Reduction in WM integrity was greater in patients with MCI who had the most intense neuronal degeneration as indexed by using CSF total tau, suggesting that these patients might represent a subgroup of MCI with more intense WM degeneration who are possibly at greater risk of developing Alzheimer disease. RSNA, 2012
Authors: Naruhiko Sahara; Pablo D Perez; Wen-Lang Lin; Dennis W Dickson; Yan Ren; Huadong Zeng; Jada Lewis; Marcelo Febo Journal: Neurobiol Aging Date: 2013-12-19 Impact factor: 4.673
Authors: Craig Ritchie; Nadja Smailagic; Anna H Noel-Storr; Obioha Ukoumunne; Emma C Ladds; Steven Martin Journal: Cochrane Database Syst Rev Date: 2017-03-22
Authors: Annie M Racine; Andrew P Merluzzi; Nagesh Adluru; Derek Norton; Rebecca L Koscik; Lindsay R Clark; Sara E Berman; Christopher R Nicholas; Sanjay Asthana; Andrew L Alexander; Kaj Blennow; Henrik Zetterberg; Won Hwa Kim; Vikas Singh; Cynthia M Carlsson; Barbara B Bendlin; Sterling C Johnson Journal: Brain Imaging Behav Date: 2019-02 Impact factor: 3.978
Authors: M Mascalchi; N Toschi; M Giannelli; A Ginestroni; R Della Nave; E Nicolai; A Bianchi; C Tessa; E Salvatore; M Aiello; A Soricelli; S Diciotti Journal: AJNR Am J Neuroradiol Date: 2015-04-16 Impact factor: 3.825
Authors: Foad Taghdiri; Namita Multani; Apameh Tarazi; Seyed Ali Naeimi; Mozghan Khodadadi; Carrie Esopenko; Robin Green; Brenda Colella; Richard Wennberg; David Mikulis; Karen Deborah Davis; Ruma Goswami; Charles Tator; Brian Levine; Maria Carmela Tartaglia Journal: Neurology Date: 2019-05-08 Impact factor: 9.910
Authors: Leonides Canuet; Sandra Pusil; María Eugenia López; Ricardo Bajo; José Ángel Pineda-Pardo; Pablo Cuesta; Gerardo Gálvez; José María Gaztelu; Daniel Lourido; Guillermo García-Ribas; Fernando Maestú Journal: J Neurosci Date: 2015-07-15 Impact factor: 6.167